Balchem Corporation

Day range

$171.10 – $178.57

Open

$178.12

Prev close

$177.00

Volume

128.9K

Market cap

$5.64B

Shares out

31.78M

P/E

33.02

P/S

5.09

P/B

4.25

P/FCF

31.70

ROE

12.9%

ROA

10.0%

Debt/Equity

0.02

Div yield

0.55%

As of Oct 23, 2026

• Quarterly earningsOct 23, 2026

  On October 23, 2026, Balchem Corporation reported earnings for the quarter ended September 30, 2026, and certain other information.

• Credit facilityJul 27, 2026

  Amendment No. 1 (the "Credit Agreement Amendment") to that certain Amended and Restated Credit Agreement, dated as of July 27, 2022... (i) increased the aggregate revolving commitment amount from $550 million to $650 million; (ii) extended the maturity date of the credit facility from July 27, 2027 to July 24, 2031; (iii) enabled the Foreign Borrower to borrow funds; (iv) eliminated the 10 basis point adjustment to the applicable SOFR rate; and (v) reduced the applicable margin for loans at Tier 3 and 4 leverage levels by 12.5 basis points in each tier.

• Annual meeting resultsJun 22, 2026

  Balchem Corporation (the "Company") held its Annual Meeting of Shareholders on June 18, 2026. The results of the matters voted on by shareholders at the Annual Meeting are set forth below: 1. The election of two Class 3 director nominees to the Board of Directors to serve until the Annual Meeting of Shareholders in 2029 and until their successors are duly elected and qualified: David Fischer received 25,318,402 votes for and Daniel Knutson received 26,755,996 votes for.

• Executive officer appointmentFeb 19, 2026

  On February 12, 2026, the Board of Directors of the Company elected Erin L. Gilson to serve as Vice President and Chief Accounting Officer, effective April 1, 2026. Ms. Gilson joined the Company in February 2016 and currently serves as Senior Director, Accounting and Financial Reporting.

• Share repurchase programDec 10, 2025

  On December 9, 2025, the Board of Directors of the Company approved a new stock repurchase program which replaces the previous program that was in place and authorizes the repurchase of up to, and including, 4 million shares of the Company's ordinary shares. This new stock repurchase program has no expiration date, does not oblige the Company to acquire any particular amount of the Company's ordinary shares, and may be terminated at any time.

• IOSPInnospec Inc.+1.63%
• FULH.B. Fuller Company-0.65%

Days to cover

2.1

Short interest

493.01K

Avg volume

236.97K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Balchem: 3 Key Takeaways for Long-Term Investors
  positiveThe Motley Fool· Oct 23, 2026
• Balchem Corporation Reports Third Quarter 2026 Financial Results
  positiveGlobeNewswire Inc.· Oct 23, 2026
• Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026
  neutralGlobeNewswire Inc.· Oct 9, 2026
• Encapsulated Lactic Acid Market Analysis Report 2026-2031 - Advanced Coating Technologies Expand Specialty Applications
  positiveGlobeNewswire Inc.· Sep 2, 2026
• Encapsulated Essential Oils for Feed Market Global Report 2026 Examines Growth Opportunities, Competitive Trends and Global Forecasts
  positiveGlobeNewswire Inc.· Jul 15, 2026